Synapse - Eileen O'Reilly

Results (786)

Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM)

Meeting Abstract

Tsang, E. S.; Shi, Q.; Olive, K. P.; Collisson, E. A.; Dixon, J. G.; Cusnir, M.; Winograd, R.; Botta, G. P.; Wadlow, R. C.; Shergill, A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer-Evaluating radiation, ablation, and surgery (ERASur)

Meeting Abstract

Miller, E. D.; Hitchcock, K.; Shi, Q.; Dixon, J. G.; Gholami, S.; White, S. B.; Wu, C.; Goulet, C. C.; Jee, K. W.; Wright, C. L.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma

Meeting Abstract

O'Reilly, E. M.; Wainberg, Z. A.; Fisher, G. A. Jr; Wolff, R. A.; Ko, A. H.; O'Hara, M. H.; Spencer, C. N.; Yu, J. X.; Da Silva, D. M.; Padron, L. J.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

AMPLIFY-7P, a first-in-human safety and efficacy trial of adjuvant mKRAS-specific lymph node targeted amphiphile ELI-002 7P vaccine in patients with minimal residual disease-positive pancreatic and colorectal cancer

Meeting Abstract

Devoe, C. E.; Pant, S.; Wainberg, Z. A.; Chung, V.; George, T. J.; Kasi, P. M.; VanWyk, H.; Tavares, A.; Perry, J.; Kheoh, T.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Alliance EAY191-A6: FOLFOX in combination with binimetinib as second-line therapy for patients with advanced biliary tract cancers (BTCs) with MAPK pathway alterations: A ComboMATCH treatment trial

Meeting Abstract

Shergill, A.; Liao, C. Y.; Elsaid, M. I.; Al Baghdadi, T.; Ji, Y.; Feldman, D.; George, S.; O'Reilly, E. M.; Meyerhardt, J. A.; Berg, S. A.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors

Meeting Abstract

Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights

Meeting Abstract

Keane, F.; Tuli, R.; O'Connor, C. A.; Schwartz, C.; Park, W.; Varghese, A. M.; Perry, M.; Singhal, A.; Vardhana, S.; Hendifar, A. E.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Does non-alcoholic fatty liver disease increase the risk for pancreatic cancer? A multi-center retrospective cohort study

Meeting Abstract

Singh, R. R.; O'Reilly, E. M.
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes

Meeting Abstract

Keane, F.; Moss, D.; O'Connor, C. A.; Perry, M.; Chou, J. F.; Crowley, F.; Saxena, P.; Chan, A.; Park, W.; Varghese, A. M.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save

Fibrolamellar carcinoma registry: Opportunities and challenges

Meeting Abstract

Al Mahmasani, L.; Capanu, M.; Losert, K.; Lowery, M. A.; Hennessy, M.; Ray, M.; Chambers, S.; Yaqubie, A.; Zarski, A.; El Dika, I. H.; more...
Journal of Clinical Oncology (2024)

Fulltext@MSK | Save